RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Were Rolling..Well let's hope you or a loved one never gets an aggresive cancer. I am sure you wouldn't reject any immunotherapy that could save your life. My wife is alive today because of the money that has been spent on cancer research. The statistics show a steep decline in cancer deaths since 1990 because of the R&D;
https://www.houstonchronicle.com/lifestyle/renew-houston/health/article/Cancer-death-rate-declines-sharply-partly-thanks-14960731.php
Cancer is a disease related to cell growth, it is extremely complex and comes in many forms. The key is to catch it early through screening thus giving the patient much better outcomes (that is MedX's technology) or having a cancer that a immunotherapy or more advanced treatment will cause to go into remision.
Investors have continued to invest in MedX and contrary to some posters here, MedX has attracted institutional investors;
https://btglobal.ca/blog/market-insights/we-invite-you-to-read-paul-beatties-feature-in-moneytalks-inside-edge-about-bt-globals-perspective-for-the-summer/
Recently, the increase in volume has occurred as MedX has been out speaking at investor conferences. I suspect that has brought some fresh eyes to the story. Unfortunately, medical investments can take a long time to unfold but MedX has recently shown a number of countries and clinic sales starting to produce revenue and I expect this trend to accelerate in 2021.GLTA